Yoon, Dok Hyun <br/><br/>
Ki-67 expression as a prognostic factor in diffuse large B-cell lymphoma patients treated with rituximab plus CHOP.  [electronic resource] 

 -  European journal of haematology  Aug 2010 
 - 149-57 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1600-0609 
<br/><br/><label>Standard No.: </label>10.1111/j.1600-0609.2010.01467.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antibodies, Monoclonal--administration & dosage<br/>Antibodies, Monoclonal, Murine-Derived<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Cell Proliferation--drug effects<br/>Cyclophosphamide--administration & dosage<br/>Doxorubicin--administration & dosage<br/>Humans<br/>Ki-67 Antigen--analysis<br/>Lymphoma, Large B-Cell, Diffuse--diagnosis<br/>Middle Aged<br/>Prednisone--administration & dosage<br/>Prognosis<br/>Recurrence<br/>Rituximab<br/>Survival Analysis<br/>Vincristine--administration & dosage<br/>Young Adult